Danny Vesprini
@dr_vesi
Radiation Oncologist @ Sunnybrook Odette Cancer Centre, father, husband, wine snob. Tweets and opinions my own.
10-11-2012 17:13:28
3,3K Tweets
1,4K Followers
1,0K Following
The ASCENDE-SBRT trial. HDR brachy+23# EBRT vs. 5# SBRT for unfavourable prostate ca. Amazing CCTG study led by Dr. Andrew Loblaw Sunnybrook Health Sciences Centre.
Can non-invasive, cheaper high precision SBRT be used to avoid invasive brachy + GA & multiple visits ?
Shift that paradigm!
